Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the first side effects of Wegovy within hours to a few days of their initial injection, with nausea being the most commonly reported early symptom. The good news is that the timing follows a fairly predictable pattern: side effects tend to peak in the first one to two days after each dose, then ease. Wegovy (semaglutide) is a prescription-only medicine, so a clinical assessment by a qualified prescriber is the right starting point for understanding what to expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is something like: "I've just done my first injection — should I be worried if I feel fine, or worried if I feel awful?" The misconception behind that question is that Wegovy side effects sneak up gradually over several weeks. In practice, the opposite is usually true: if gastrointestinal symptoms are going to appear, they tend to show up fast, and how soon side effects of Wegovy start is something many people are surprised to learn about before their first injection.
The NHS medicines page for semaglutide confirms that stomach-related effects (including nausea, diarrhoea, constipation, and indigestion) are the most common reactions to treatment. They are also most pronounced at the very start of treatment and after each dose increase, precisely because your system is adjusting to the medicine's effect on gastric emptying and appetite signalling.
So if you felt queasy the evening of your first Wegovy injection, that is not a warning sign that something has gone wrong. It is the expected biology. Most people find that by days three or four of each injection cycle, their stomach has settled considerably. A minority do not feel much at all, and that is equally normal. How long Wegovy side effects last varies person to person, but the first injection is rarely representative of the whole journey.
Semaglutide slows how quickly your stomach empties, and that single mechanism explains most of what people experience early on. Food sits longer, you feel full faster, and your gut has to recalibrate. The result for many people is nausea, burping, a vague stomach heaviness, or looser stools. Some people also notice tiredness or a mild headache in the first couple of days.
These effects are real, sometimes uncomfortable, and worth knowing about in advance. They are also, for the majority, temporary. The licensed dosing schedule for Wegovy starts deliberately low for this reason, allowing your body to adapt before the dose increases. Detailed information on managing these early symptoms is in the Wegovy SmPC on the eMC, and it is worth reading before your first pen.
For a fuller picture of the range of side effects associated with Wegovy across treatment, the Wegovy side effects overview covers what the clinical data shows beyond the first weeks. One thing worth knowing: nausea tends to be the dominant early complaint, but it does not mean treatment is not working.
Most of what people feel in the first few days on Wegovy is mild to moderate and resolves on its own. But some symptoms should not be waited out. Seek urgent medical attention if you develop severe, persistent abdominal pain, particularly if it radiates through to your back, this can be a sign of acute pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Similarly, symptoms of a gallbladder problem (sharp pain under your right ribs, especially after eating fatty food) or signs of severe dehydration from repeated vomiting should prompt a call to 111 or a visit to your GP.
Allergic reactions are rare but important to know: swelling of the face or throat, difficulty breathing, and a rapid heartbeat all need emergency attention. If you are curious about how soon side effects from Wegovy typically appear relative to your injection, that can also help you distinguish a reaction to the medicine from something unrelated.
If you experience any side effect that concerns you, speak to your prescriber. And any suspected adverse reaction can be reported to the MHRA directly, the Yellow Card scheme exists precisely so that real-world data on medicines like Wegovy continues to be gathered after approval. That's not a bureaucratic box-tick; it genuinely helps future patients.
By weeks four to eight for most people, the stomach-related side effects that were noticeable in the first fortnight have quietened significantly. The body adapts. Nausea that felt persistent after the first injection is often barely noticeable by the second or third. Some people find that eating smaller portions, staying well hydrated, and avoiding very fatty or spicy food makes the early weeks considerably more manageable, though personal dietary plans should always be discussed with your prescriber.
If side effects are still substantially affecting daily life after several weeks at the same dose, that is a clinical conversation worth having sooner rather than later. Dose timing, eating habits, and hydration can all be reviewed. Occasionally, the pace of dose escalation is adjusted. The dry mouth that some people notice on Wegovy is a good example of a symptom that feels odd but is usually manageable with simple adjustments.
At nume, our prescribers go through all of this during the consultation, not as a disclaimer, but as a practical preparation for what the first few weeks actually feel like. If you want to understand more about how Wegovy fits your situation before committing, checking your eligibility through a free consultation is the natural first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.